Key Financials Snapshot

TTM · Standalone · ₹ in Cr
Market Cap
₹241 Cr.
Stock P/E
2992.2
P/B
4
Current Price
₹115.7
Book Value
₹ 29.2
Face Value
10
52W High
₹153
52W Low
₹ 97.6
Dividend Yield
0%

Lotus Eye Hospital Overview

Business

Lotus Eye Hospital And Institute Ltd. is an Indian healthcare services provider specializing in comprehensive ophthalmic care. The company operates a chain of eye hospitals, offering a wide range of services including consultations, diagnostic procedures, and surgical treatments for various eye conditions. Its core business model revolves around providing medical expertise and advanced technology for eye care. The company generates revenue primarily through fees charged for patient consultations, diagnostic tests, surgical procedures (such as cataract, LASIK, glaucoma, and retinal surgeries), optical services, and pharmacy sales.

Revenue Mix

While specific segmental revenue breakdown is not provided, the company's revenue is derived entirely from its ophthalmic healthcare services. This typically includes:

Surgical Procedures: A significant portion, especially from high-volume surgeries like cataract and refractive error corrections (LASIK).

Outpatient Consultations & Diagnostics: Fees from doctor visits, eye examinations, and advanced diagnostic tests.

Optical & Pharmacy Sales: Revenue from dispensing spectacles, contact lenses, and eye-related medications.

Given the nature of an "Eye Hospital And Institute," surgical and advanced medical treatments are likely the dominant revenue drivers.

Industry

The Indian hospital and healthcare services industry is highly fragmented but growing rapidly, driven by an aging population, rising lifestyle diseases, increasing health awareness, and growing insurance penetration. The eye care segment specifically benefits from a high prevalence of vision impairment and blindess, particularly cataracts, alongside a growing demand for refractive surgeries. Lotus Eye Hospital And Institute operates within this competitive landscape, positioning itself as a provider of specialized eye care. Its standing versus peers would depend on its geographical footprint, reputation for specific specialties, technology adoption, and pricing strategy within its operational regions. It likely competes with both large corporate hospital chains (which may have eye care departments) and other dedicated standalone eye care chains and smaller independent clinics.

MOAT

Lotus Eye Hospital And Institute Ltd. may possess the following competitive advantages:

Brand Reputation & Trust: In healthcare, patient trust built over years of quality service and successful outcomes is a significant advantage, leading to repeat business and referrals.

Specialized Medical Expertise: A strong team of experienced ophthalmologists and support staff can be a differentiator, particularly for complex procedures.

Established Patient Base: A long-standing presence in its operating regions can lead to a loyal patient base.

Moderate Switching Costs: Patients often prefer to continue treatment with doctors or hospitals they are familiar with, especially for chronic conditions or follow-up care.

Localized Scale: If it has a network of hospitals in specific regions, it can benefit from localized brand recall and operational efficiencies.

Growth Drivers

Aging Population: India's increasing elderly population drives demand for age-related eye conditions like cataracts, glaucoma, and diabetic retinopathy.

Lifestyle Changes & Awareness: Increased screen time contributes to eye strain and dry eyes, while rising health awareness encourages early detection and treatment.

Increasing Disposable Income & Health Insurance: Growing middle-class income and penetration of health insurance make advanced eye care more accessible and affordable.

Technological Advancements: Adoption of new diagnostic tools and surgical techniques (e.g., advanced phacoemulsification, femtosecond laser for LASIK) can attract more patients and improve outcomes.

Expansion: Opening new centers or increasing capacity at existing hospitals in underserved or high-demand areas.

Medical Tourism: Potential to attract patients from neighboring countries for specialized treatments.

Risks

Intense Competition: The eye care segment is competitive, with numerous standalone hospitals, corporate chains, and unorganized players vying for patients.

Reliance on Key Personnel: High dependence on skilled ophthalmologists; attrition of key doctors could impact service quality and patient flow.

Regulatory Changes: Healthcare regulations, pricing controls for medical procedures or devices, and quality standards can impact profitability and operations.

Technology Obsolescence & Capital Expenditure: Continuous need to invest in advanced and expensive medical equipment to remain competitive.

Reputational Risk: Medical errors, service quality issues, or patient dissatisfaction can severely damage reputation and patient trust.

Economic Downturns: Elective procedures might be postponed by patients during economic slowdowns, impacting revenue.

Management & Ownership

As a publicly listed company in India, Lotus Eye Hospital And Institute Ltd. typically has a promoter group (often the founding family or individuals) holding a significant stake, along with institutional investors and public shareholders. The quality of management would involve their strategic vision for growth, ability to attract and retain medical talent, operational efficiency, and adherence to ethical practices. Without specific details, it is difficult to assess individual management quality, but their ability to navigate the competitive healthcare landscape and maintain quality standards is crucial.

Outlook

Lotus Eye Hospital And Institute operates in a sector with significant underlying demand tailwinds driven by India's demographics, increasing health awareness, and improving affordability of healthcare. The long-term growth trajectory for eye care services appears robust. However, the company faces inherent challenges including intense competition, the need for continuous technological upgrades, and the critical reliance on skilled medical professionals. The ability to maintain high service quality, manage operational costs efficiently, expand strategically, and navigate potential regulatory shifts will be key determinants of its continued success and market positioning. While the demand for eye care offers a strong foundation, sustained competitive advantage and prudent management are essential for long-term value creation in this dynamic industry.

Lotus Eye Hospital Share Price

Live · BSE / NSE · Inception: 1997
₹ | |
Volume
Price

Key Financials — Profit & Loss

₹ in Cr · Standalone · annual

Lotus Eye Hospital Quarterly Results

#(Fig in Cr.) Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026 Jun 2026
Net Sales 11 13 13 12 12 14 13 14 14 17
Other Income 0 0 0 0 1 0 0 0 0 0
Total Income 11 13 13 12 12 14 13 14 14 17
Total Expenditure 10 11 12 11 12 12 12 13 13 14
Operating Profit 1 2 1 1 0 2 1 1 1 3
Interest 0 0 0 0 0 0 0 0 0 1
Depreciation 1 1 1 1 -1 1 1 1 1 2
Exceptional Income / Expenses 0 0 0 -0 0 0 0 0 -0 -0
Profit Before Tax 0 1 0 -0 1 1 0 -0 -0 1
Provision for Tax -0 0 0 -0 1 0 -0 -0 -0 0
Profit After Tax 0 1 0 -0 0 1 0 -0 -0 1
Adjustments -0 -0 0 -0 0 -0 0 0 0 -0
Profit After Adjustments 0 1 0 -0 0 1 0 -0 -0 1
Adjusted Earnings Per Share 0 0.3 0 -0.1 0.1 0.3 0.1 -0.1 -0.2 0.3

Lotus Eye Hospital Profit & Loss

#(Fig in Cr.) Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026 TTM
Net Sales 31 34 38 38 41 32 39 47 48 50 54 58
Other Income 1 1 1 1 1 1 1 1 1 1 1 0
Total Income 32 35 39 39 41 33 40 48 50 51 55 58
Total Expenditure 28 31 34 35 37 29 33 39 42 46 50 52
Operating Profit 4 4 5 4 5 4 7 9 8 5 5 6
Interest 0 0 0 0 0 0 0 0 0 0 1 1
Depreciation 4 3 3 3 2 2 3 3 4 3 4 5
Exceptional Income / Expenses 0 -0 0 -0 -1 0 -0 -0 0 0 -0 0
Profit Before Tax -0 0 2 1 1 2 4 6 4 1 -0 1
Provision for Tax -0 -0 -0 -0 0 0 1 2 1 1 -0 0
Profit After Tax 0 0 2 1 1 2 3 4 3 1 0 1
Adjustments 0 0 0 0 0 0 0 0 0 0 0 0
Profit After Adjustments 0 0 2 1 1 2 3 4 3 1 0 1
Adjusted Earnings Per Share 0 0.2 0.8 0.3 0.5 0.8 1.4 2 1.4 0.4 0 0.1

Lotus Eye Hospital Balance Sheet

#(Fig in Cr.) Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Shareholder's Funds 49 50 51 50 51 53 55 58 59 60 60
Minority's Interest 0 0 0 0 0 0 0 0 0 0 0
Borrowings 0 0 0 0 0 0 0 0 0 0 10
Other Non-Current Liabilities 0 -0 -0 -0 0 -0 1 0 1 2 3
Total Current Liabilities 5 4 7 6 6 6 6 5 6 7 9
Total Liabilities 55 55 57 56 57 58 61 63 66 69 82
Fixed Assets 44 41 43 44 43 41 44 44 49 54 66
Other Non-Current Assets 5 6 7 5 4 4 4 4 4 4 5
Total Current Assets 6 7 8 7 11 14 13 15 14 12 11
Total Assets 55 55 57 56 57 58 61 63 66 69 82

Lotus Eye Hospital Cash Flow

#(Fig in Cr.) Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Opening Cash & Cash Equivalents 1 2 3 4 3 7 10 9 4 5 2
Cash Flow from Operating Activities 3 3 6 4 5 3 4 4 6 3 3
Cash Flow from Investing Activities -1 -1 -4 -4 -1 0 -4 -2 -4 -4 -12
Cash Flow from Financing Activities -1 -0 -2 -1 0 -0 -2 -2 -3 -2 9
Net Cash Inflow / Outflow 2 2 0 -1 4 3 -1 0 -1 -3 -0
Closing Cash & Cash Equivalent 2 3 4 3 7 10 9 9 3 2 2

Lotus Eye Hospital Ratios

# Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Earnings Per Share (Rs) 0.05 0.21 0.84 0.34 0.51 0.75 1.44 1.96 1.4 0.36 0.04
CEPS(Rs) 1.79 1.87 2.46 1.81 1.71 1.87 2.64 3.39 3.19 1.8 1.84
DPS(Rs) 0 0.5 0.5 0 0 0.5 0.5 0.5 0.5 0 0
Book NAV/Share(Rs) 23.8 24.07 24.35 24.1 24.65 25.34 26.26 27.69 28.57 28.85 28.92
Core EBITDA Margin(%) 10.21 9.8 11.44 8.39 9.82 11.23 15.25 16.35 13.76 7.18 6.62
EBIT Margin(%) 0.43 1.67 4.95 2.19 4.17 6.58 11.07 12.45 8.74 3.76 1.82
Pre Tax Margin(%) -0.07 1.23 4.48 1.63 3.59 6.15 10.52 12.01 8.33 2.79 -0.1
PAT Margin (%) 0.32 1.31 4.59 1.84 2.63 4.84 7.67 8.67 6.05 1.49 0.15
Cash Profit Margin (%) 11.97 11.44 13.46 9.8 8.78 12.04 14.1 15 13.78 7.56 7.13
ROA(%) 0.18 0.81 3.12 1.25 1.89 2.71 4.99 6.58 4.51 1.09 0.11
ROE(%) 0.2 0.89 3.47 1.41 2.1 3.02 5.56 7.27 4.98 1.24 0.13
ROCE(%) 0.27 1.13 3.71 1.66 3.32 4.07 8 10.43 7.19 3.1 1.47
Receivable days 5.06 6.41 8.74 9.03 6.41 7.9 6.4 6.97 9.2 9.5 8.6
Inventory Days 34.39 24.61 20.1 21.58 19.21 21.95 19.16 19.77 22.72 25.93 26.04
Payable days 117.66 86.95 108.13 110.55 87.95 106.98 96.13 81.76 78.7 80.52 72.5
PER(x) 329.07 173.07 33.28 65.07 45.52 55.57 37.18 29.62 40.31 196.62 2618.86
Price/Book(x) 0.67 1.54 1.15 0.92 0.95 1.65 2.03 2.1 1.98 2.42 3.5
Dividend Yield(%) 0 1.35 1.79 0 0 1.19 0.94 0.86 0.89 0 0
EV/Net Sales(x) 1.01 2.18 1.44 1.14 1.03 2.39 2.63 2.39 2.3 2.86 4.08
EV/Core EBITDA(x) 8.36 18.29 10.48 11.2 8.55 17.7 14.99 12.71 13.95 29.18 46.31
Net Sales Growth(%) 4.13 9.1 11.95 1.06 5.54 -20.18 20.21 20.9 2.48 2.81 8.38
EBIT Growth(%) 106.43 319.87 231.35 -55.3 101.06 25.78 102.31 35.94 -28.03 -55.79 -47.6
PAT Growth(%) 105.09 340.48 293.4 -59.47 50.37 47.29 90.33 36.63 -28.52 -74.63 -89.12
EPS Growth(%) 105.09 340.48 293.4 -59.47 50.38 47.29 90.33 36.62 -28.52 -74.63 -89.11
Debt/Equity(x) 0.01 0.01 0.01 0 0.01 0.01 0 0 0 0.01 0.2
Current Ratio(x) 1.38 1.61 1.16 1.17 1.79 2.34 2.24 2.83 2.21 1.56 1.22
Quick Ratio(x) 0.77 1.18 0.82 0.79 1.43 2.03 1.83 2.3 1.71 1.04 0.81
Interest Cover(x) 0.87 3.78 10.39 3.93 7.13 15.52 20.09 28.69 20.98 3.88 0.95
Total Debt/Mcap(x) 0.02 0.01 0.01 0 0.01 0 0 0 0 0 0.06

Growth Rates

Compounded annual
# 1 Year 3 Year 5 Year 10 Year
Sales CAGR +8% +5% +11% +6%
Operating Profit CAGR 0% -18% +5% +2%
PAT CAGR -100% -100% -100% —
Share Price CAGR -6% +12% +19% +20%
ROE Average 0% +2% +4% +3%
ROCE Average +1% +4% +6% +4%

Lotus Eye Hospital Shareholding Pattern

Latest · Jun 2026
100% held
Promoters 40.14 %
FII 0 %
DII (MF + Insurance) 0 %
Public (retail) 59.86 %
# Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026 Jun 2026
Promoter 41.440.2440.0340.1440.2240.3940.6440.6740.1440.14
FII 000000.0100.0100
DII 0000000000
Public 58.659.7659.9759.8659.7859.659.3659.3359.8659.86
Others 0000000000
Total 100100100100100100100100100100

Lotus Eye Hospital Peer Comparison

Hospital & Healthcare Services Edit Columns

Lotus Eye Hospital Quarterly Price

10-year quarterly close · BSE
Show Value Show %

News & Updates

See more…

Lotus Eye Hospital Pros & Cons

Pros

  • Debtor days have improved from 80.52 to 72.5days.
  • Company is almost debt free.

Cons

  • Promoter holding is low: 40.14%.
  • Company has a low return on equity of 2% over the last 3 years.
  • Stock is trading at 4 times its book value.
  • The company has delivered a poor profit growth of -100% over past five years.
Want to Start Investing in Top Unlisted Stocks?

Our experts help you choose the right stocks based on performance, risk, and growth potential.

whatsapp